Aktiv Medical Systems offers the PenPal® autoinjector platform
Uniquely positioned to address pharmaceutical companies need for self-administration of large-dose injections
PenPal® seamlessly integrates exceptional design simplicity with superior performance, reliability, and platform versatility. Our vision is to leverage our capabilities and innovative PenPal® autoinjector technology to support pharmaceutical and biopharmaceutical partners in need of high-performance autoinjectors. We are dedicated to addressing underserved market segments that require injection dose volumes larger than 2.25 ml and/or high-viscosity formulations.
PenPal® Overview – Complexity Simplified!
Aktiv conceived a unique and differentiated approach, resulting in an extremely simple design architecture, consisting of very low part count and minimal mechanical interfaces between subsystems
Enabling, patented “Direct Drive” technology
6 molded parts and 4 off-the-shelf components
Device simplicity leads to superior reliability and versatility unmatched by any autoinjector
No other autoinjector can handle the entire range of standard drug containers & dose load
Direct Drive: Unlike any other commercially available autoinjector, PenPal® patented technology applies direct compressed gas pressure to the primary drug container for needle insertion, medication delivery and full needle retraction